Quanta: a David to Dialysis Industry Goliaths
Standard HD is burdensome, costly, labor-intensive, and has poor outcomes, and patients want more autonomy and flexibility. Enter Quanta: a novel HD system that combines high performance, a small footprint, and ease of use.
Read the full article » | Posted 10-12-2020
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

